Session Information
AABB Annual Meeting and CTTXPO 2010
Click here to go to the previous page
Application of HPCs in Cardiovascular Diseases
Track
:
TC- Technical/Clinical
Program Code:
9303-TC-CT
Date:
Monday, October 11, 2010
Time:
8:30 AM to 10:00 AM
EST
Location:
307
DIRECTOR
:
Grace S. Kao, MD, Assistant Medical Director, Cell Manipulation Core Facility/Dana-Farber
MODERATOR
:
Grace S. Kao, MD, Assistant Medical Director, Cell Manipulation Core Facility/Dana-Farber
SPEAKER
(S):
Rajesh Gupta, MD, Instructor, Northwestern University
Abba Zubair, MD, PhD
Samer Mansour, MD, CSPQ, Cardiologist, Montreal University hospital center
Description
The session will address the use of unfractionated marrow and CD34+ or CD133+ enriched HPCs in the treatment of cardiovascular disease. The rationale and clinical outcome of the studies will be addressed by clinical experts leading the clinical trials. Panel discussion will follow for questions and answers.
- Determine the rationale for using different subset's of HPCs for treatment of cardiovascular disease.
- Discuss future implications of HPCs therapy in cardiovascular disease.
- Review outcomes from current heart studies using HPCs.
| CE Category | CE Value |
|---|---|
| California Clinical Laboratory Personnel | 1.5 |
| California Nurse | 1.8 |
| Florida Laboratory Personnel | 1.8 |
| General Attendee | 1.5 |
| Physician | 1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.
This session is a part of:
Online Access
(Code: 9303-TC-CT)
Attendee/Member:$25 USD
Attendee:$40 USD
Member:$40 USD
Non-Attendee/Non-Member $50 USD - Your Price
This session is a part of:
 | Copyright © 2014 by MultiView, Inc. All website graphics, text, design, software, and other works are the copyrighted works of MultiView, Inc. All audio, video, presentation materials, logos and text are the copyrighted works of their respective owners. All Rights Reserved. Any redistribution or reproduction of any materials herein is strictly prohibited. |  |